DALLAS, TEXAS--(Marketwired - Dec. 23, 2013) - This report "Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018" by MarketsandMarkets, defines and segments the Mice Model market into various sub-segments with an in-depth analysis and forecasting of revenues.
Browse 116 market data tables and 85 figures spread through 339 pages and in-depth TOC on "Mice Model Market"
The global Mice Model Market is estimated at $1,115.2 million in 2013 and is expected to reach $1,819.9 million by 2018, growing at a CAGR of 10.3% from 2013 to 2018. Market is categorized into four broad segments. The mice model market, by type, comprises of inbred, outbred, congenic/hybrid, surgically modified, knockout, and spontaneous mutant mice. The market for technology is segmented into microinjection, embryonic stem cell technique, virus/vector, nuclear transferase, genetically modified sperm, and others. By disease, the Mice Model Market is segmented into diabetes, CNS, oncology, cardiovascular, immunology and inflammation, metabolism and regulation, and others. The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). The report also includes the mice care products market, which includes cages, feed, bedding, and others.
The expanding global biotechnology and pharmaceutical industries and increasing government investments, funds, and grants have stimulated the usage of advanced mice models in the biotechnology and pharmaceutical industries. North America accounts for the largest share of the Mice Model Market. Asia is expected to witness a high growth in the Mice Model Market in the forecast period. The major players in the Mice Model Market include Charles River Laboratories (U.S.), The Jackson Laboratory (U.S.), Taconic farms, Inc. (U.S.), genOway S.A. (France), Covance, Inc. (U.S.), Crescendo Biologics Limited (U.K.), Deltagen, Inc. (U.S.), Harbour Antibodies BV (The Netherlands), Harlan Laboratories, Inc. (U.S.), TransGenic, Inc. (U.S.), SAGE Labs (U.S.), inGenious Targeting Laboratory, Inc. (U.S.), Lexicon Pharmaceuticals, ImmunoGenes AG (Switzerland), Mirimus, Inc. (U.S.), and Ablexis LLC (U.S.).
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports & serve as a business intelligence partner to Fortune 500 companies across the world.